BLADDER CANCER IN 2011 The dawn of personalized medicine

被引:4
作者
Flaig, Thomas W. [1 ]
Theodorescu, Dan [1 ]
机构
[1] Univ Colorado, Ctr Comprehens Canc, Aurora, CO 80045 USA
关键词
PHASE-III; P53; CHEMOTHERAPY; CARCINOMA; CISPLATIN; THERAPY; TRIAL;
D O I
10.1038/nrurol.2011.220
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:65 / 66
页数:2
相关论文
共 9 条
[1]   ACCUMULATION OF NUCLEAR P53 AND TUMOR PROGRESSION IN BLADDER-CANCER [J].
ESRIG, D ;
ELMAJIAN, D ;
GROSHEN, S ;
FREEMAN, JA ;
STEIN, JP ;
CHEN, SC ;
NICHOLS, PW ;
SKINNER, DG ;
JONES, PA ;
COTE, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (19) :1259-1264
[2]   p53 and chemosensitivity [J].
Ferreira, CG ;
Tolis, C ;
Giaccone, G .
ANNALS OF ONCOLOGY, 1999, 10 (09) :1011-1021
[3]   International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial [J].
Griffiths, Gareth .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (16) :2171-2177
[4]   Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer [J].
Grossman, HB ;
Natale, RB ;
Tangen, CM ;
Speights, VO ;
Vogelzang, NJ ;
Trump, DL ;
White, RWD ;
Sarosdy, MF ;
Wood, DP ;
Raghavan, D ;
Crawford, ED .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (09) :859-866
[5]   Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder [J].
Gui, Yaoting ;
Guo, Guangwu ;
Huang, Yi ;
Hu, Xueda ;
Tang, Aifa ;
Gao, Shengjie ;
Wu, Renhua ;
Chen, Chao ;
Li, Xianxin ;
Zhou, Liang ;
He, Minghui ;
Li, Zesong ;
Sun, Xiaojuan ;
Jia, Wenlong ;
Chen, Jinnong ;
Yang, Shangming ;
Zhou, Fangjian ;
Zhao, Xiaokun ;
Wan, Shengqing ;
Ye, Rui ;
Liang, Chaozhao ;
Liu, Zhisheng ;
Huang, Peide ;
Liu, Chunxiao ;
Jiang, Hui ;
Wang, Yong ;
Zheng, Hancheng ;
Sun, Liang ;
Liu, Xingwang ;
Jiang, Zhimao ;
Feng, Dafei ;
Chen, Jing ;
Wu, Song ;
Zou, Jing ;
Zhang, Zhongfu ;
Yang, Ruilin ;
Zhao, Jun ;
Xu, Congjie ;
Yin, Weihua ;
Guan, Zhichen ;
Ye, Jiongxian ;
Zhang, Hong ;
Li, Jingxiang ;
Kristiansen, Karsten ;
Nickerson, Michael L. ;
Theodorescu, Dan ;
Li, Yingrui ;
Zhang, Xiuqing ;
Li, Songgang ;
Wang, Jian .
NATURE GENETICS, 2011, 43 (09) :875-878
[6]   Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75 [J].
Hahn, Noah M. ;
Stadler, Walter M. ;
Zon, Robin T. ;
Waterhouse, David ;
Picus, Joel ;
Nattam, Sreenivasa ;
Johnson, Cynthia S. ;
Perkins, Susan M. ;
Waddell, Mary Jane ;
Sweeney, Christopher J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (12) :1525-1530
[7]   Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer [J].
Said, Neveen ;
Smith, Steven ;
Sanchez-Carbayo, Marta ;
Theodorescu, Dan .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (01) :132-147
[8]   A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment [J].
Smith, Steven Christopher ;
Baras, Alexander Spyridon ;
Dancik, Garrett ;
Ru, Yuanbin ;
Ding, Kuan-Fu ;
Moskaluk, Christopher A. ;
Fradet, Yves ;
Lehmann, Jan ;
Stoeckle, Michael ;
Hartmann, Arndt ;
Lee, Jae K. ;
Theodorescu, Dan .
LANCET ONCOLOGY, 2011, 12 (02) :137-143
[9]   Phase III Study of Molecularly Targeted Adjuvant Therapy in Locally Advanced Urothelial Cancer of the Bladder Based on p53 Status [J].
Stadler, Walter M. ;
Lerner, Seth P. ;
Groshen, Susan ;
Stein, John P. ;
Shi, Shan-Rong ;
Raghavan, Derek ;
Esrig, David ;
Steinberg, Gary ;
Wood, David ;
Klotz, Laurence ;
Hall, Craig ;
Skinner, Donald G. ;
Cote, Richard J. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (25) :3443-3449